Heidi Klepin(@HKlepinMD) 's Twitter Profileg
Heidi Klepin

@HKlepinMD

Geriatric oncologist

ID:4025148473

calendar_today23-10-2015 15:46:46

3,0K Tweet

1,1K Takipçi

315 Takip Edilen

Follow People
Cancer and Aging Research Group (CARG) #GeriOnc(@myCARG) 's Twitter Profile Photo

JAGS launched an ongoing Diversity in Research on Aging series that examines diversity in research. 1st article highlights the insufficient research on health disparities among older cancer survivors: agsjournals.onlinelibrary.wiley.com/doi/full/10.11…

@AGSJournal launched an ongoing Diversity in Research on Aging series that examines diversity in research. 1st article highlights the insufficient research on health disparities among older cancer survivors: agsjournals.onlinelibrary.wiley.com/doi/full/10.11… #GeriOnc #DEI #AGS #CARG #SIOG #ASCO
account_circle
U of I School of Molecular and Cellular Biology(@MCB_Illinois) 's Twitter Profile Photo

Two alumni with ties to U of I School of Molecular and Cellular Biology will receive Alumni Achievement Awards Friday from U of I College of LAS
We are so excited to celebrate Lisa Monteggia and Ruben Mesa!

More about their remarkable careers:

Dr. Mesa: go.mcb.illinois.edu/rubenm
Dr. Monteggia: go.mcb.illinois.edu/lisam

Two alumni with ties to @MCB_Illinois will receive Alumni Achievement Awards Friday from @LASillinois We are so excited to celebrate Lisa Monteggia and Ruben Mesa! More about their remarkable careers: Dr. Mesa: go.mcb.illinois.edu/rubenm Dr. Monteggia: go.mcb.illinois.edu/lisam
account_circle
Ruben A. Mesa, MD(@mpdrc) 's Twitter Profile Photo

Novel “Time Without Transfusion” metric for quantifying the cumulative benefit of anemia in myelofibrosis patients treated with momelotinib: ⁦⁦GSK⁩ ⁦Wake Forest Baptist - Comprehensive Cancer Center⁩ ⁦Levine CancerAtrium Health⁩ ⁦Atrium HealthWFB⁩

Novel “Time Without Transfusion” metric for quantifying the cumulative benefit of anemia in myelofibrosis patients treated with momelotinib: #ASH23 #mpnsm ⁦⁦@GSK⁩ ⁦@WakeCancer⁩ ⁦@LevineCancer⁩ #LevineCancer ⁦@AtriumHealth⁩ ⁦@AtriumHealthWFB⁩
account_circle
Ashley Rosko(@Ashley_Rosko1) 's Twitter Profile Photo

CHARM PIs: Artz & Mohamed Sorror 1226 enrolled.Wowsa! very feasible GA 7 factors influenced NRM. Memory 🧠and PATIENT reported KPS. First prospective GA in transplant. 🤜🙌🙌

CHARM #ASH23 PIs: Artz & @msorror 1226 enrolled.Wowsa! very feasible GA 7 factors influenced NRM. Memory 🧠and PATIENT reported KPS. First prospective GA in transplant. 🤜🙌🙌
account_circle
Megan Moore Weivoda(@MegVoda) 's Twitter Profile Photo

Melissa (Kah Poh) Loh, MBBCh BAO, MS, FACCC⁩ presenting the impact of chemotherapy on epigenetic age and whether this could be mitigated by exercise intervention at the ⁦ASH⁩ FSW on Hematology and Aging

⁦@MelissaLoh21⁩ presenting the impact of chemotherapy on epigenetic age and whether this could be mitigated by exercise intervention at the ⁦@ASH_hematology⁩ FSW on Hematology and Aging
account_circle
Mazie Tsang, MD, MAS, MS(@MazieTsangMD) 's Twitter Profile Photo

Melissa (Kah Poh) Loh, MBBCh BAO, MS, FACCC shows that a median ⬆️ of 300 steps using a mobile health app can slow down epigenetic changes of aging associated with worse outcomes

⭐️ I am going to exercise more and prescribe exercise to my patients!!

@MelissaLoh21 shows that a median ⬆️ of 300 steps using a mobile health app can slow down epigenetic changes of aging associated with worse outcomes #geriheme #ASH23 ⭐️ I am going to exercise more and prescribe exercise to my patients!!
account_circle
Katherine Ansley, MD(@KatherineAnsley) 's Twitter Profile Photo

Have been looking forward to this data on INAVO120 after serving as the local PI for this trial Wake Forest Baptist - Comprehensive Cancer Center. Happy to see the data today supports what we saw in clinic to overcome endocrine resistance with improved PFS with triplet therapy in PIK3CA mutated BC

Have been looking forward to this data on INAVO120 after serving as the local PI for this trial @WakeCancer. Happy to see the data today supports what we saw in clinic to overcome endocrine resistance with improved PFS with triplet therapy in PIK3CA mutated BC #SABCS23
account_circle
Megan Moore Weivoda(@MegVoda) 's Twitter Profile Photo

Dr. Rebecca Hesterberg starting off the ⁦ASH⁩ FSW on hematology and aging with her work demonstrating that lymphoma induces an aging phenotype in T cells

Dr. Rebecca Hesterberg starting off the ⁦@ASH_hematology⁩ FSW on hematology and aging with her work demonstrating that lymphoma induces an aging phenotype in T cells #geriheme
account_circle